Medtronic to Showcase Innovative Medical Technologies at the Third China International Import Expo

Shanghai, September 16, 2020 /PRNewswire/ -- As the countdown to the third China International Import Expo (CIIE) reaches 50 days, Medtronic officially announces its participation in the event scheduled for November 5–10. In this extraordinary year of 2020, marked by the global pandemic challenge, Medtronic will showcase a series of innovative products. These include critical care medical solutions that support epidemic prevention and control, as well as cutting-edge smart therapies designed to safeguard public health in the post-pandemic era. By presenting a vision of future healthcare, Medtronic demonstrates its steadfast commitment to advancing human health through medical technology.

Over the past two years, thanks to the extensive and profound impact of the China International Import Expo (CIIE) as an open platform, many of Medtronic’s cutting-edge therapeutic technologies have garnered attention from professionals, patients, and the general public, accelerating the implementation of these innovative achievements in China. One of the “star exhibits” at the first two CIIEs – Medtronic Micra^TMThe transcatheter pacing system was officially launched in November 2019, marking China’s formal entry into the era of leadless pacing for arrhythmia management. Leveraging the “Nine National Measures” pilot program and the green channel for import approval, the next-generation cryoballoon cathode showcased at the Second China International Import Expo (CIIE) was used in its inaugural procedure in January at Hainan Boao Super Hospital. Furthermore, in accordance with emergency import regulations for unregistered medical devices in Hubei Province during the pandemic, Medtronic donated a CARPEDIEM neonatal hemodialysis system—making its Chinese debut at the Second CIIE—to the Hubei Provincial Maternal and Child Health Hospital free of charge through the Hubei Charity Federation.

Amid the backdrop of pandemic prevention and control, this year’s China International Import Expo kicked off, with Medtronic set to showcase a series of “powerful tools” for fighting the epidemic, includingThe World’s First Long-Acting Oxygenator with Integrated Monitoring FunctionNautilus Smart Next-Generation Extracorporeal Membrane Oxygenation (ECMO) TechnologyECMO; Continuous Blood Purification Device for Resisting Cytokine StormEquasmart; Key Medical Equipment for Treating COVID-19 PatientsPB980Ventilator andPB560Ventilators; and providing patients with "Internet" in the post-pandemic era+"Smart Healthcare" Convenient Management Model'sCareLink Express MobilePacemaker Follow-up Platform。

In addition, Medtronic will showcase a series of globally leading innovative therapies and products at the China International Import Expo (CIIE), featuring innovative solutions across six key areas: neurosurgery and spine surgery, cardiac and vascular, smart surgery, digestive and liver health, diabetes management, and hemodialysis, includingProfessional Intelligent Spinal Robot System Debuted to the Chinese PublicMazor X Stealth Edition；Micra^TMTranscatheter Pacing SystemSeries of New Products --Micra^TMDual-chamber pacing system completes its first clinical application in China at Boao Lecheng, Hainan；The world’s first biodegradable pancreaticobiliary stent; the world’s first deep brain stimulator with commercially viable sensing technologyPercept^TM PCand other medical technology products.

“During the pandemic, Medtronic promptly rushed to support the front lines of the fight against the epidemic, with multiple therapies and products playing a positive role in treating critically ill patients with COVID-19. In the post-pandemic era, Medtronic will continue to leverage innovative medical technologies to safeguard Healthy China under normalized epidemic prevention and control.” Said Gu Yushao, Senior Vice President of Medtronic globally and President of Greater China, “We hope to use the China International Import Expo as a window showcasing medical innovation to explore the forefront of medical technology with the Chinese public, and work hand in hand with various partners to promote a healthier future.”